Market valued at $1.68B in 2024, projected to reach $4.58B by 2033 at 13.4% CAGR, driven by chronic wound prevalence ...
Q4 2025 Earnings Call February 12, 2026 4:30 AM ESTCompany ParticipantsTakehiko Tsutsui - CEO & President & President ...